en · de · es · fr · pt
lab-handbook.peptides3081.com › Wiki › Origin And Telomerase Research Claims — Reference Sheet

Origin And Telomerase Research Claims — Reference Sheet

By Editorial Desk · published 2026-06-22 · last reviewed 2026-07-27 · Wiki

counterion is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-07-27. Numbers and descriptions here follow the published literature rather than marketing material.

Origin and Telomerase Research Claims

Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.

The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.

Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.

Handling, Storage and Analytical Checks

Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.

Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.

Epitalon at a glance

PropertyValueNotes
Peptide sequenceAla-Glu-Asp-GlySingle-letter form AEDG
Compound classSynthetic tetrapeptideNot a natural free peptide
Research originRussian gerontology institutesDeveloped during the 1990s
Main research claimTelomerase activationEvidence mainly from cultured cells
Regulatory statusNot an approved drugHandled as a research material

Analytical Characterization and Stability

Identity testing for epitalon relies on reversed-phase high-performance liquid chromatography for purity and mass spectrometry for mass confirmation. Because the sequence contains no tryptophan or tyrosine, ultraviolet detection at 280 nanometres is insensitive, so chromatographic methods usually monitor absorbance near 214 nanometres, where the peptide backbone absorbs. Electrospray ionisation or matrix-assisted laser desorption/ionisation then checks the intact mass against the expected value near 390 daltons. Peptide mapping or amino acid analysis after acid hydrolysis can supplement these measurements, although such confirmatory work is seldom reported on commercial certificates of analysis.

Stability of the tetrapeptide follows ordinary peptide chemistry rather than any unusual structural feature. The aspartate-glycine pair is prone to aspartimide formation under mildly basic or neutral conditions, and deamidation can follow, altering both mass and chromatographic retention. Dry lyophilised powder kept at or below minus twenty degrees Celsius is the usual handling recommendation, with repeated freeze-thaw cycles avoided. Once dissolved in neutral aqueous buffer, degradation proceeds over days to weeks depending on pH and temperature, while acidic conditions generally slow the aspartimide route. A formal stability-indicating study has not been published in the indexed literature.

Because epitalon has no pharmacopoeial monograph, quality assessment depends on supplier documentation and independent testing. Certificates of analysis typically report a purity figure from a single chromatographic run, a measured mass and sometimes an appearance description, but methods and acceptance criteria are not harmonised across vendors. Third-party laboratories can repeat identity and purity measurements, and mismatches between labelled and measured peptide content have been described for research peptides generally. What constitutes adequate identity confirmation for a molecule of this size stays an open question, since mass agreement alone does not separate closely related sequences.

Related pages on this site

Notes from published material

A 58-hour curfew was announced in Kherson. Oleksandr Prokudin, the Ukrainian governor of Kherson Oblast, said that during the curfew: "it is forbidden to move on the streets of the city. The city will also be closed for entry and exit". Twenty-four civilians were killed in Kherson city due to Russian shelling. Russia said it had shot down two drones over the Moscow Kremlin and accused Ukraine of sending them to assassinate President Vladimir Putin. The Institute for the Study of War commented that it was "extremely unlikely that two drones could have penetrated multiple layers of air defence and detonated or been shot down just over the heart of the Kremlin in a way that provided spectacular imagery caught nicely on camera". The Ukrainian government denied the accusations, calling them fabricated. The British Ministry of Defence reported that several unmanned aerial vehicles (UAVs) struck Russia's Seshcha Airbase in Bryansk Oblast, 150 km north of the Ukrainian border, adding that an An-124 heavy transport aircraft was likely damaged.

== Licenses and collaborations == In January 2008, Rosetta Genomics announced a collaboration agreement with the Henry Ford Health System in Detroit, Michigan to develop microRNA-based diagnostics and prognostics for brain cancer. Also in January 2008, Rosetta Genomics announced that its subsidiary, Rosetta Genomics Inc. has received a license to use Roche Molecular Systems' PCR technology in microRNA-based diagnostic tests. In September 2007, Rosetta Genomics said it will work with New York University Medical Center to develop a microRNA-based diagnostic test for melanoma. In May 2007, Rosetta Genomics announced Columbia University Medical Center would utilize its Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory to perform the clinical validation of Rosetta Genomics’ diagnostics program for cancer of unknown primary. In February 2006, Isis Pharmaceuticals Inc. and Rosetta Genomics said they will collaborate to develop antisense drugs that inhibit microRNA in the liver to treat cancers there. Antisense drugs are a class of compounds that interfere with genetic material that gets translated into harmful proteins.

=== N05CD Benzodiazepine derivatives === N05CD01 Flurazepam N05CD02 Nitrazepam N05CD03 Flunitrazepam N05CD04 Estazolam N05CD05 Triazolam N05CD06 Lormetazepam N05CD07 Temazepam N05CD08 Midazolam N05CD09 Brotizolam N05CD10 Quazepam N05CD11 Loprazolam N05CD12 Doxefazepam N05CD13 Cinolazepam N05CD14 Remimazolam N05CD15 Nimetazepam

== Side effects == Like ketamine, etoxadrol produces increases in heart rate and respiratory rate. Etoxadrol may also cause vomiting. At high enough doses, etoxadrol also exhibits effects on the muscular system such as convulsions or loss of the righting reflex. When administered in excess, etoxadrol can be lethal on the respiratory system. Monkeys given extremely high (> 20 mg/kg) doses of etoxadrol died of apparent respiratory failure. Etoxadrol produces a wide variety of dreams, ranging from pleasant to frightening or aversive. Approximately half of patients given etoxadrol report pleasant dreams, 25% report unpleasant dreams, and the remaining 25% experience no dreams at all. Such dreams were frequently described as “floating,” “puffy” or “out of this world." Dreams and hallucinations may persist for as long as 18 to 24 hours. In rare cases, etoxadrol can induce periods of psychotic activity during this recovery period. In the brain, etoxadrol slows down the synthesis of serotonin to 50-60% of control rates and speeds up the rate of dopamine synthesis by up to 200% of the normal rate 4–6 hours after intravenous administration. Like a number of other drugs (e.g. cocaine), etoxadrol has been found to exhibit reinforcing properties. Monkeys will self-administer etoxadrol, dexoxadrol or PCP in a lever-pressing paradigm.

Sources: en.wikipedia.org

Background from the literature

The first observations and size measurements of nano-particles were made during the first decade of the 20th century. Zsigmondy made detailed studies of gold sols and other nanomaterials with sizes down to 10 nm and less. He published a book in 1914. He used an ultramicroscope that employs a dark field method for seeing particles with sizes much less than light wavelength. There are traditional techniques developed during the 20th century in interface and colloid science for characterizing nanomaterials. These are widely used for first generation passive nanomaterials specified in the next section. These methods include several different techniques for characterizing particle size distribution. This characterization is imperative because many materials that are expected to be nano-sized are actually aggregated in solutions. Some of methods are based on light scattering. Others apply ultrasound, such as ultrasound attenuation spectroscopy for testing concentrated nano-dispersions and microemulsions. There is also a group of traditional techniques for characterizing surface charge or zeta potential of nano-particles in solutions. This information is required for proper system stabilization, preventing its aggregation or flocculation. These methods include microelectrophoresis, electrophoretic light scattering, and electroacoustics. The last one, for instance colloid vibration current method is suitable for characterizing concentrated systems.

Missions played a variety of roles in the postwar world: the mission in San Francisco assisted participants in the meeting that established the United Nations, the mission in Europe acquired European publications for the Library of Congress and other American libraries, and the mission in Japan aided in the creation of the National Diet Library.

==== Systemic lupus erythematosus ==== Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Studies have implicated a role for neutrophil death (NETosis) in SLE. Neutrophil ferroptosis is prevalent in patients with SLE and is induced by autoantibodies and interferon-alpha (IFN-α), which suppress GPX4 expression via the transcriptional repressor CREMα. Inhibition of ferroptosis was able to ameliorate SLE disease progression in the MRL/lpr mouse model of SLE.

Sources: en.wikipedia.org

Further detail

=== Asthma === The 2007 National Heart, Lung, and Blood Institute (NHLBI) asthma guidelines recommend against the use of non-selective beta blockers in asthmatics, while allowing for the use of cardio selective beta blockers. Cardio selective beta blocker (β1 blockers) can be prescribed at the least possible dose to those with mild to moderate respiratory symptoms. β2-agonists can somewhat mitigate β-blocker-induced bronchospasm where it exerts greater efficacy on reversing selective β-blocker-induced bronchospasm than the nonselective β-blocker-induced worsening asthma and/or COPD.

=== Synthesis === Researchers at Cubist Pharmaceuticals (prior to the acquisition of Cubist by Merck) discovered and developed a synthesis of ceftolozane sulfate based on a palladium-mediated coupling in the presence of the cephalosporin nucleus, marking a significant advancement in the chemistry of cephalosporin antibiotics. This chemistry was determined to be general to the family of cephalosporin antibiotics. Key elements of the coupling reaction were the use of a designed, electron-deficient phosphite ligand in tandem with the addition of an exogenous chloride scavenging reagent, which functioned through the in situ precipitation of potassium chloride. This work is described only in the patent literature.

Kasuzuke is a type of Japanese tsukemono pickling and marinating process that uses sake kasu as one of the main ingredients. Kasuzuke can be used to marinade different ingredients such as cucumber, daikon, salmon, or chicken The first step of creating Kasuzuke is to create a mixture that contains sake kasu, miso, mirin or sake, sugar, and salt. The ratio can be different for personal preference. Next, add the ingredients that into the mixture and allow the marinade to permeate the food. The Kasuzuke can be eaten raw or cooked depending on whether the ingredient added to the Kasuzuke requires cooking or not in order to consume safely.

Tajima Beef: Tajima beef is beef from the Tajima region of Hyōgo Prefecture, and has a history of about 1,200 years. Kobe Beef: Kobe Beef is a brand given to the highest quality beef from Hyōgo Prefecture's Tajima cattle and has a history of about 170 years. Special Matsusaka Beef: Special Matsuzaka Beef (Tokusan Matsusaka Ushi) is a brand given to the highest quality virgin female beef from the Matsuzaka region of Mie Prefecture. The Matsusaka beef brand has a history of about 100 years. Yonezawa Beef: Yonezawa Beef (Yonezawa Gyu) is beef from virgin Japanese black female cattle in the Okitama region of Yamagata Prefecture and has a history of about 150 years. Maesawa Beef: Maesawa Beef is a brand given to the highest quality beef from the Maesawa area of Iwate Prefecture, and has a history of about 70 years. Miyazaki Beef: Miyazaki Beef is a brand of wagyu beef from Miyazaki Prefecture, and has often won the Wagyu Olympics in recent years. Ōmi Beef: Ōmi Beef is a wagyu beef brand from Shiga Prefecture with a history of about 400 years. Kagoshima Black Beef: Kagoshima Black Beef (Kagoshima Kuroushi) is a wagyu beef brand from Kagoshima Prefecture that won the recent Wagyu Olympics. Kumamoto Red Beef: Kumamoto Red Beef (Kuamoto Akaushi) is a wagyu beef from Kumamoto Prefecture, characterized by its lean meat. Hiba Beef: Hiba Beef is a brand of Japanese black cattle from Shobara City, Hiroshima Prefecture, with a history dating back to the Edo period. Hida Beef: Hida Beef is a Japanese beef from Gifu Prefecture and has a history of about 100 years.

Sources: en.wikipedia.org

Frequently asked questions

Who developed epitalon?

Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.

Does epitalon lengthen telomeres in humans?

That question is not settled. Cell culture studies have reported increased telomerase activity after treatment, but comparable evidence from controlled human trials is lacking. Any claim about telomere lengthening in people should be treated as unproven.

Why is epitalon not an approved medicine?

It has not completed the large, controlled trials required for drug approval in major jurisdictions. Most human reports involve small samples and limited follow-up. As a result, it is sold as a research chemical rather than a licensed pharmaceutical product.

How should epitalon powder be stored?

Sealed lyophilised powder is normally kept at minus twenty degrees Celsius or below, away from light and moisture. Vials are allowed to reach room temperature before opening to limit condensation. Repeated warming and cooling of the same vial is discouraged.

Network